[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351420-105":59,"doc-detail-351420-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","high-expression-of-papp-a-predicts-poor-outcomes-in-oestrogen-receptor-positive-breast-cancer-patients","High Expression of PAPP-A Predicts Poor Outcomes in Oestrogen Receptor-Positive Breast Cancer Patients","","Insulin-like growth factor 1 (IGF-1)/IGF-1 receptor (IGF-1R) signalling supports breast cancer progression, and pregnancy-associated plasma protein-A (PAPP-A) can release bioactive IGF-1 by cleaving IGF binding proteins. Breast cancer tissue microarrays were used to measure PAPP-A in tumour and stromal compartments, correlating expression with survival and clinical features. Public datasets further assessed links between PAPP-A and IGF-1/IGF-1R pathway activation gene sets. High PAPP-A predicted reduced cancer-specific survival in ER+ patients, including ER+ invasive lobular carcinoma, and correlated with PI3K-AKT and IGF1R signalling gene sets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/high-expression-of-papp-a-predicts-poor-outcomes-in-oestrogen-receptor-positive-breast-cancer-patients/351420/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/high-expression-of-papp-a-predicts-poor-outcomes-in-oestrogen-receptor-positive-breast-cancer-patients/351420.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is PAPP-A and how is it linked to IGF-1 signalling in breast cancer?","Question",{"text":112,"@type":113},"PAPP-A is a metalloproteinase that cleaves IGF binding proteins, enabling release of bioactive IGF-1 and activation of IGF-1 signalling through IGF-1R.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was PAPP-A expression measured and related to clinical outcomes?",{"text":117,"@type":113},"PAPP-A expression was assessed using breast cancer tissue microarrays stained for PAPP-A, with expression correlated to survival and other clinical features.",{"name":119,"@type":110,"acceptedAnswer":120},"Which patient subgroup showed an association between high PAPP-A and poorer prognosis?",{"text":121,"@type":113},"High PAPP-A expression was associated with reduced cancer-specific survival in oestrogen receptor-positive (ER+) breast cancer patients, and similarly in a second cohort of ER+ invasive lobular carcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351420,1790689599,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nHigh Expression of PAPP-A Predicts Poor Outcomes in Oestrogen Receptor-Positive Breast Cancer Patients  \nZeanap Mabruk1 | Esme Bullock1 | Xue Xiao2  | Jingjing Guo2 | Xuan Zhu2 | Laura Gómez-Cuadrado1 | Claus Oxvig3 | Elizabeth Mallon4 | Aula Ammar5  | Amna Malty5 | Kathryn Pennel5  | Joanne Edwards5  | Valerie G. Brunton1   \n1Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, UK | 2Department of Pathology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China | 3Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark | 4Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK | 5School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK  \nCorrespondence: Valerie G. Brunton ([v.brunton@ed.ac.uk](v.brunton@ed.ac.uk))  \nReceived: 3 July 2025 | Revised: 12 February 2026 | Accepted: 2 April 2026  \nKeywords: breast cancer | IGF-1 signalling | invasive lobular carcinoma | pregnancy-associated plasma protein-A  \nABSTRACT  \nIntroduction: Insulin-like growth factor 1 (IGF-1)/IGF-1 receptor (IGF-1R) signalling is activated in breast cancer and associated with disease progression. Pregnancy-associated plasma protein-A (PAPP-A) is a metalloproteinase that can cleave IGF binding proteins leading to the release of bioactive IGF-1 and the subsequent activation of IGF-1 signalling. Here, we aimed to assess the prognostic significance of PAPP-A in breast cancer.  \nMethods: Breast cancer tissue microarrays were stained for PAPP-A and expression correlated with survival and other clinical features. Analysis of publicly available data sets was carried out to determine associations between PAPPA and gene sets associated with IGF-1/IGF-1R pathway activation.  \nResults: PAPP-A was expressed in both the tumour and stromal compartments in breast cancer specimens and was higher inoestrogen receptor (ER)-negative (ER-) than ER-positive (ER+) cases. There was a significant association between high PAPP-A expression and reduced cancer-specific survival (CSS) in ER+ (HR 1.389, 95% CI 1.051–1.836, p = 0.021) but not ER-patients (HR 1.040, 95% CI 0.712–1.598, p = 0.838) . In a second cohort of ER+ invasive lobular carcinoma (ILC) PAPP-A expression was also associated with reduced CSS (HR 1.765, 95% CI 1.098–2.836, p = 0.019) . PAPPA correlated with REACTOME PI3K-AKT and IGF1R signalling gene sets in ER+ breast cancers.  \nConclusion: High expression of PAPP-A is associated with poor prognosis in ER+ breast cancer and correlates with IGF-1/ IGF-1R pathway activation.  \n1 | Introduction  \nInsulin-like growth factor 1 (IGF-1) signalling is a complex and highly regulated pathway that plays a crucial role in mammary gland development and also in the initiation and progression of breast cancer [1–3] . Binding of IGF-1 to its cognate receptor IGF-1R triggers its autophosphorylation and activation, leading to downstream activation of signalling pathways via the insulin receptor substrate 1 (IRS-1) . The two predominant IGF-1  \nresponsive pathways are the phosphatidylinositol 3-kinase/AKTkinase (PI3K/AKT) pathway and the RAF kinase/mitogen activated protein kinase (RAF/MAPK) pathway, which can both provide proliferative and survival signals [1, 2] .  \nSeveral studies have shown strong associations between IGF-1R pathway activation and clinical outcomes in breast cancer patients and other tumour types [4–6], which has led to the development of strategies to target IGF-1/IGF-1R  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2026; 15:e71815 1 of 12  \n","cbCainWVwWHtJvtM","https://ap.wps.com/l/cbCainWVwWHtJvtM","pdf",4318870,12,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is PAPP-A and how is it linked to IGF-1 signalling in breast cancer?\",\"answer\":\"PAPP-A is a metalloproteinase that cleaves IGF binding proteins, enabling release of bioactive IGF-1 and activation of IGF-1 signalling through IGF-1R.\"},{\"question\":\"How was PAPP-A expression measured and related to clinical outcomes?\",\"answer\":\"PAPP-A expression was assessed using breast cancer tissue microarrays stained for PAPP-A, with expression correlated to survival and other clinical features.\"},{\"question\":\"Which patient subgroup showed an association between high PAPP-A and poorer prognosis?\",\"answer\":\"High PAPP-A expression was associated with reduced cancer-specific survival in oestrogen receptor-positive (ER+) breast cancer patients, and similarly in a second cohort of ER+ invasive lobular carcinoma.\"}]","High Expression of PAPP-A Predicts Poor Outcomes in Oestrogen Receptor-Positive Breast Cancer Patients | PDF",1790094071,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d13c353db396f1fe9b63f41f5abe47e.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25084dd05e61bd7fb4543dfd1e5e9f4c.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/447d04b25e5cd762d6f42c10f0585b0b.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3275e621014053605b071546217dd2fb.webp",980,1287]